The Union Health Ministry has come up with draft New Drugs and Clinical Trials (Amendment) Rules, inserting provisions for "compassionate use" of any unapproved drug that is in the phase-III clinical trial, either in India or abroad, by importing or indigenous manufacturing. The move is aimed at facilitating availability of new drugs which are in Phase-III clinical trials (human trials) for severely-ill COVID-19 patients in the country.from IndiaTV: Google News Feed https://ift.tt/3dTQJ7e
Post a Comment